Dexepicatechin
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Dexepicatechin
- DrugBank Accession Number
- DB19253
- Background
Dexepicatechin is under investigation in clinical trial NCT02964377 (Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 290.271
Monoisotopic: 290.079038171 - Chemical Formula
- C15H14O6
- Synonyms
- (+)- Epicatechin
- (+)-Epicatechin
- (2s,3s)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
- 2h-1-benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2s-cis)-
- D-epicatechin
- Dexepicatechin
- Ent-epicatechin
- Epicatechin, (+)-
- Epicatechin, d-
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- LD6B6TT8Q5
- CAS number
- 35323-91-2
- InChI Key
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N
- InChI
- InChI=1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15+/m0/s1
- IUPAC Name
- SMILES
- O[C@H]1CC2=C(O)C=C(O)C=C2O[C@H]1C1=CC=C(O)C(O)=C1
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0037954
- KEGG Compound
- C09728
- ChemSpider
- 158494
- BindingDB
- 50135167
- ChEBI
- 76125
- ChEMBL
- CHEMBL129482
- ZINC
- ZINC000000119978
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data2 Completed Treatment Friedreich's Ataxia 1 somestatus stop reason just information to hide 1 Completed Treatment Becker's Muscular Dystrophy (BMD) 1 somestatus stop reason just information to hide 1 Completed Treatment Impaired Glucose Tolerance 2 somestatus stop reason just information to hide 1, 2 Completed Treatment Duchenne Muscular Dystrophy (DMD) 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at July 11, 2024 20:31 / Updated at July 12, 2024 11:45